User login
- /content/bexarotene-confers-no-survival-benefit-mycosis-fungoides
- /edermatologynews/article/48950/melanoma/bexarotene-confers-no-survival-benefit-mycosis-fungoides
- /familypracticenews/article/48950/melanoma/bexarotene-confers-no-survival-benefit-mycosis-fungoides
- /internalmedicinenews/article/48950/melanoma/bexarotene-confers-no-survival-benefit-mycosis-fungoides
- /oncologypractice/article/48950/melanoma/bexarotene-confers-no-survival-benefit-mycosis-fungoides
- /hematology-oncology/article/48950/melanoma/bexarotene-confers-no-survival-benefit-mycosis-fungoides
- /internalmedicine/article/48950/melanoma/bexarotene-confers-no-survival-benefit-mycosis-fungoides
- /dermatology/article/48950/melanoma/bexarotene-confers-no-survival-benefit-mycosis-fungoides
- /familymedicine/article/48950/melanoma/bexarotene-confers-no-survival-benefit-mycosis-fungoides